Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mizrachi

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
European Journal of Clinical Microbiology|December 1, 1983
Waterborne outbreak of Campylobacter enteritisM Rogol, I Sechter, H Falk, et al.
Clinical Immunology (Orlando, Fla.)|January 13, 1999
Linomide induces apoptotic death of cortical CD4/CD8 double positive thymocytes and thymic atrophy by a corticosteroid-independent pathwayI Arbel, E Chezen, O Abramsky, et al.
Journal of Neuroimmunology|November 6, 2001
The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitisD Karussis, O Abramsky, N Grigoriadis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1992
Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantationD M Karussis, S Slavin, D Lehmann, et al.
Journal of Neuro-Oncology|January 1, 1987
Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration studyT Siegal, U Sandbank, A Gabizon, et al.
Journal of Neuroimmunology|December 1, 1994
Immunomodulation of experimental autoimmune myasthenia gravis with linomideD M Karussis, D Lehmann, T Brenner, et al.
Journal of Neuroimmunology|April 1, 1997
Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitisD Lehmann, D M Karussis, D Fluresco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitisD Karussis, D M Michaelson, N Grigoriadis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide)D M Karussis, D Lehmann, S Slavin, et al.
The Journal of Clinical Investigation|August 1, 1993
Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantationD M Karussis, U Vourka-Karussis, D Lehmann, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Clinical Microbiology|December 1, 1983
Waterborne outbreak of Campylobacter enteritisM Rogol, I Sechter, H Falk, et al.
Clinical Immunology (Orlando, Fla.)|January 13, 1999
Linomide induces apoptotic death of cortical CD4/CD8 double positive thymocytes and thymic atrophy by a corticosteroid-independent pathwayI Arbel, E Chezen, O Abramsky, et al.
Journal of Neuroimmunology|November 6, 2001
The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitisD Karussis, O Abramsky, N Grigoriadis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1992
Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantationD M Karussis, S Slavin, D Lehmann, et al.
Journal of Neuro-Oncology|January 1, 1987
Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration studyT Siegal, U Sandbank, A Gabizon, et al.
Journal of Neuroimmunology|December 1, 1994
Immunomodulation of experimental autoimmune myasthenia gravis with linomideD M Karussis, D Lehmann, T Brenner, et al.
Journal of Neuroimmunology|April 1, 1997
Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitisD Lehmann, D M Karussis, D Fluresco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitisD Karussis, D M Michaelson, N Grigoriadis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide)D M Karussis, D Lehmann, S Slavin, et al.
The Journal of Clinical Investigation|August 1, 1993
Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantationD M Karussis, U Vourka-Karussis, D Lehmann, et al.
Pageof 3